Chenguang Ouyang

Title: Chenguang Ouyang: Innovator in Peptide Compounds

Introduction

Chenguang Ouyang is a notable inventor based in Bloomington, IN (US). She has made significant contributions to the field of peptide compounds, particularly in the development of glucagon analogs. Her work focuses on compounds that exhibit both glucagon antagonist and GLP-1 agonist activity.

Latest Patents

Chenguang Ouyang holds a patent for "Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity." This patent describes glucagon analogs that demonstrate both glucagon antagonist and GLP-1 agonist activity. In one embodiment, the glucagon antagonist/GLP-1 agonist comprises a modified amino acid sequence of native glucagon, where the first one to five N-terminal amino acids of native glucagon are deleted, and the alpha helix is stabilized. She has 1 patent to her name.

Career Highlights

Chenguang Ouyang is affiliated with Indiana University, where she continues her research and development in the field of peptide compounds. Her innovative work has the potential to impact therapeutic approaches in metabolic disorders.

Collaborations

Some of her notable coworkers include Richard Dennis DiMarchi and Bin Yang, who have also contributed to advancements in peptide research.

Conclusion

Chenguang Ouyang is a pioneering inventor whose work in peptide compounds is paving the way for new therapeutic options. Her contributions to the field are significant and continue to influence research in glucagon and GLP-1 activity.